Cited by 171Pancreatic function and diabetesDiabetes and associated disordersDiabetes Management and Research

The DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.

The journey of islet cell transplantation and future development

Open access

Gamble, Anissa, Pepper, Andrew R., Bruni, Antonio, Shapiro, A. M. James·2018·Islets

DOI 10.1080/19382014.2018.1428511PMC PMC5895174

Open this paper in CoChat — free account Open PDF

Abstract

Intraportal islet transplantation has proven to be efficacious in preventing severe hypoglycemia and restoring insulin independence in selected patients with type 1 diabetes. Multiple islet infusions are often required to achieve and maintain insulin independence. Many challenges remain in clinical islet transplantation, including substantial islet cell loss early and late after islet infusion. Contributions to graft loss include the instant blood-mediated inflammatory reaction, potent host auto- and alloimmune responses, and beta cell toxicity from immunosuppressive agents. Protective strategies are being tested to circumvent several of these events including exploration of alternative transplantation sites, stem cell-derived insulin producing cell therapies, co-transplantation with mesenchymal stem cells or exploration of novel immune protective agents. Herein, we provide a brief introduction and history of islet cell transplantation, limitations associated with this procedure and methods to alleviate islet cell loss as a means to improve engraftment outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/19382014.2018.1428511

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
Self-citation
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Microencapsulated Islets as Bioartificial Endocrine Pancreas
Lim, F., & Sun, A. M. (1980) · Science · doi:10.1126/science.6776628 · Cited by 2,377
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells
D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O., Agulnick, A. D., Smart, N. G., Moorman, M. A., KROON, E. J., Carpenter, M. K., & Baetge, E. E. (2006) · Nature Biotechnology · doi:10.1038/nbt1259 · Cited by 1,913
Human mesenchymal stem cells modulate B-cell functions
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2657 · Cited by 1,767

Show all 133 references

Research works printed but not linked: 14

Banting FG, 1922, Can Med Assoc J, 12, 141
Williams P, 1894, Br Med J, 2, 1303
Ballinger WF, 1972, Surgery, 72, 175
Brendel M HB, University of Giessen, 1999, 1
Szot GL, 2007, J Vis Exp, 404
Weber CJ, 1978, Surgery, 84, 166
Stagner JI, 2007, JOP, 8, 628
10.1177/096368979500400308 · DOI
Ferguson J, 1977, J Anat, 124, 1
Gala-Lopez B. L. PAR, 2016, CellR4, 4, e2132
Algire GH, 1954, J Natl Cancer Inst, 15, 493
Fu L, 2017, Zhonghua Nei Ke Za Zhi, 56, 273
L. G-LB, 2016, CellR4, 4, 2066
Friedenstein AJ, 1966, J Embryol Exp Morphol, 16, 381

Sorted by citations

Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges
Sneddon, J. B., Tang, Q., Stock, P. G., Bluestone, J. A., Roy, S., Desai, T. A., & Hebrok, M. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.05.016 · Cited by 252
Advancements in the Use of Hydrogels for Regenerative Medicine: Properties and Biomedical Applications
Revete, A., Aparicio, A., Cisterna, B. A., Revete, J., Luis, L., Ibarra, E., González, E. A. S., Molino, J. J., & Reginensi, D. (2022) · International Journal of Biomaterials · doi:10.1155/2022/3606765 · Cited by 256
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.002 · Cited by 210
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.
Reichman, T. W., Markmann, J. F., Odorico, J., Witkowski, P., Fung, J. J., Wijkstrom, M., Kandeel, F., de Koning, E. J. P., Peters, A. L., Mathieu, C., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2506549 · Cited by 177
Glucose Response by Stem Cell-Derived β Cells In Vitro Is Inhibited by a Bottleneck in Glycolysis
Davis, J. C., Alves, T., Helman, A., Chen, J. C., Kenty, J. H. R., Cardone, R., Liu, D. R., Kibbey, R., & Melton, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107623 · Cited by 105
Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives
Pathak, V., Pathak, N., O’Neill, C. L., Guduric‐Fuchs, J., & Medina, R. J. (2019) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551419844521 · Cited by 144
Improvement of islet transplantation by the fusion of islet cells with functional blood vessels
Nalbach, L., Roma, L. P., Schmitt, B. M., Becker, V., Körbel, C., Wrublewsky, S., Pack, M., Später, T., Metzger, W., Menger, M. M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012616 · Cited by 106
Automation, Monitoring, and Standardization of Cell Product Manufacturing
Doulgkeroglou, M.-N., Nubila, A. D., Nießing, B., König, N., Schmitt, R. H., Damen, J., Szilvassy, S. J., Chang, W. Y., Csontos, L., Louis, S. A., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00811 · Cited by 98
New advances in type 1 diabetes
Subramanian, S., Khan, F. N., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 105
Modulating the foreign body response of implants for diabetes treatment
Kharbikar, B. N., Chendke, G. S., & Desai, T. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.011 · Cited by 85
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 88
Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices
Oliveira, S. M. R., Rebocho, A., Ahmadpour, E., Nissapatorn, V., & Pereira, M. D. L. (2023) · Micromachines · doi:10.3390/mi14010151 · Cited by 92
Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois, S., Sawatani, T., Mulders, A. V., Leu, N. D., Heremans, Y., Heimberg, H., Cnop, M., & Staels, W. (2021) · Cells · doi:10.3390/cells10010191 · Cited by 73
Endothelial Progenitor Cell‐Derived Extracellular Vesicles: A Novel Candidate for Regenerative Medicine and Disease Treatment
Xing, Z., Zhao, C. F., Liu, H., & Fan, Y. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000255 · Cited by 68
Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes
Goswami, D., Domingo‐Lopez, D. A., Ward, N. A., Millman, J. R., Duffy, G. P., Dolan, E. B., & Roche, E. T. (2021) · Advanced Science · doi:10.1002/advs.202100820 · Cited by 72
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats
Paez‐Mayorga, J., Campa‐Carranza, J. N., Capuani, S., Hernandez, N., Liu, H., Chua, C. Y. X., Pons-Faudoa, F. P., Malgir, G., Alvarez, B., Niles, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35629-z · Cited by 64
Engineering designer beta cells with a CRISPR-Cas9 conjugation platform
Lim, D., Sreekanth, V., Cox, K. J., Law, B. K., Wagner, B. K., Karp, J. M., & Choudhary, A. (2020) · Nature Communications · doi:10.1038/s41467-020-17725-0 · Cited by 59
Generation of insulin‐secreting organoids: a step toward engineering and transplanting the bioartificial pancreas
Wassmer, C., Lebreton, F., Bellofatto, K., Bosco, D., Berney, T., & Berishvili, E. (2020) · Transplant International · doi:10.1111/tri.13721 · Cited by 58
Shaping Pancreatic β-Cell Differentiation and Functioning: The Influence of Mechanotransduction
Galli, A., Marku, A., Marciani, P., Schulte, C., Lenardi, C., Paolo, M., Maffioli, E., Tedeschi, G., & Perego, C. (2020) · Cells · doi:10.3390/cells9020413 · Cited by 51
Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation
Paez‐Mayorga, J., Capuani, S., Hernandez, N., Farina, M., Chua, C. Y. X., Blanchard, R., Sizovs, A., Liu, H., Fraga, D. W., Niles, J. A., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120232 · Cited by 54
Pancreas-on-a-Chip Technology for Transplantation Applications
Abadpour, S., Aizenshtadt, A., Olsen, P. A., Shoji, K., Wilson, S. R., Krauss, S. J. K., & Scholz, H. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01357-1 · Cited by 52
Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells
Arroyave, F., Montaño, D., & Lizcano, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228685 · Cited by 52
Microvessel Network Formation and Interactions with Pancreatic Islets in Three-Dimensional Chip Cultures
Rambøl, M. H., Han, E. X., & Niklason, L. E. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2019.0186 · Cited by 46
Considerations and challenges of islet transplantation and future therapies on the horizon
Walker, S. L. M., Appari, M., & Forbes, S. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2021 · Cited by 47
The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment
Cheng, Y., Wang, H., & Li, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108524 · Cited by 45
Current status of porcine islet xenotransplantation
Coe, T. M., Markmann, J., & Rickert, C. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000794 · Cited by 30
Macroencapsulation Devices for Cell Therapy
Liu, W., Wang, Y., Wang, J., Lanier, O. L., Wechsler, M. E., Peppas, N. A., & Gu, Z. (2022) · Engineering · doi:10.1016/j.eng.2021.10.021 · Cited by 38
Toward 3D-bioprinting of an endocrine pancreas: A building-block concept for bioartificial insulin-secreting tissue
Salg, G., Poisel, E., Neulinger-Muñoz, M., Gerhardus, J., Cebulla, D., Bludszuweit-Philipp, C., Vieira, V., Nickel, F., Herr, I., Blaeser, A., et al. (2021) · bioRxiv · doi:10.1177/20417314221091033 · Cited by 33
Mimicking nature-made beta cells: recent advances towards stem cell-derived islets
Tremmel, D. M., Mitchell, S. A., Sackett, S. D., & Odorico, J. S. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000687 · Cited by 37
Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis
Liu, W., Lau, H., Son, D. O., Jin, T., Yang, Y., Zhang, Z., Li, Y., Prud’homme, G. J., & Wang, Q. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0315 · Cited by 38
Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells
Iworima, D. G., Baker, R. K., Ellis, C. E., Sherwood, C., Zhan, L., Rezania, A., Piret, J. M., & Kieffer, T. J. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03574-3 · Cited by 36
No Time to Die—How Islets Meet Their Demise in Transplantation
Kale, A., & Rogers, N. M. (2023) · Cells · doi:10.3390/cells12050796 · Cited by 37
Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
Shi, Y., Zhao, Y., Jiang, Z., Wang, Z., Wang, Q., Kou, L., & Yao, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923241 · Cited by 33
Bioengineering the Vascularized Endocrine Pancreas: A Fine-Tuned Interplay Between Vascularization, Extracellular-Matrix-Based Scaffold Architecture, and Insulin-Producing Cells
Pignatelli, C., Campo, F., Neroni, A., Piemonti, L., & Citro, A. (2022) · Transplant International · doi:10.3389/ti.2022.10555 · Cited by 33
Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates
Stock, A. A., Gonzalez, G. C., Pete, S. I., Toni, T. D., Berman, D. M., Rabassa, A., Díaz, W., Geary, J. C., Willman, M. A., Jackson, J. M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm3145 · Cited by 31
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
Lian, X.-F., Lu, D.-H., Liu, H., Liu, Y.-J., Han, X.-Q., Yang, Y., Lin, Y., Zeng, Q., Huang, Z., Xie, F., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i10.877 · Cited by 27
RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells
Simaeys, D. V., Fuente, A. D. L., Zilio, S., Zoso, A., Kuznetsova, V. Е., Alcazar, O., Buchwald, P., Grilli, A., Caroli, J., Bicciato, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29377-3 · Cited by 26
Islet transplantation-immunological challenges and current perspectives
Kabakchieva, P., Assyov, Y. S., Gerasoudis, S., Vasilev, G., Peshevska-Sekulovska, M., Sekulovski, M., Lazova, S., Miteva, D., Gulinac, M., Tomov, L., et al. (2023) · World Journal of Transplantation · doi:10.5500/wjt.v13.i4.107 · Cited by 30
Selection for CD26− and CD49A+ Cells From Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice
Molakandov, K., Berti, D. A., Beck, A., Elhanani, O., Walker, M., Soen, Y., Yavriyants, K., Zimerman, M., Volman, E., Toledo, I., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635405 · Cited by 20
Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
Huang, Q., Huang, Y., & Liu, J. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9938658 · Cited by 25
Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation
Campa‐Carranza, J. N., Paez‐Mayorga, J., Chua, C. Y. X., Nichols, J. E., & Grattoni, A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2076834 · Cited by 29
Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus
Siwakoti, P., Rennie, C., Huang, Y., Li, J. J., Tuch, B. E., McClements, L., & Xu, X. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10482-1 · Cited by 26
Engineered Biomaterials for Enhanced Function of Insulin‐Secreting β‐Cell Organoids
Hunckler, M. D., & García, A. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000134 · Cited by 24
Self-Assembling Peptides as an Emerging Platform for the Treatment of Metabolic Syndrome
Díaz, L., Ruiz‐Pacheco, J. A., Elsawy, M. A., Reyes-Martínez, J. E., & Enríquez-Rodríguez, A. I. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s278189 · Cited by 23
The Influence of Microenvironment on Survival of Intraportal Transplanted Islets
Yan, L., Ye, L., Chen, Y., He, S.-Q., Zhang, C., Mao, X., & Li, S.-W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.849580 · Cited by 24
Methionine metabolism regulates pluripotent stem cell pluripotency and differentiation through zinc mobilization
Sim, E. Z., Enomoto, T., Shiraki, N., Furuta, N., Kashio, S., Kambe, T., Tsuyama, T., Arakawa, A., Ozawa, H., Yokoyama, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111120 · Cited by 26
Islet cell encapsulation – Application in diabetes treatment
Opara, A., Jost, A., Dagogo-Jack, S. E., & Opara, E. C. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211040503 · Cited by 22
Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors
Fontcuberta-PiSunyer, M., García-Alamán, A., Prades, È., Téllez, N., Alves-Figueiredo, H., Ramos-Rodríguez, M., Enrich, C., Fernández-Ruiz, R., Cervantes, S., Clua, L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04627-2 · Cited by 16
Islet cell transplantation in children
Balamurugan, A. N., Elder, D. A., Abu‐El‐Haija, M. A., & Nathan, J. D. (2020) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2020.150925 · Cited by 20
Economics of Beta-Cell Replacement Therapy
Bandeiras, C., Hwa, A. J., Cabral, J. M. S., Ferreira, F. C., Finkelstein, S. N., & Gabbay, R. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1203-9 · Cited by 19
Building Biomimetic Potency Tests for Islet Transplantation
Glieberman, A. L., Pope, B. D., Melton, D., & Parker, K. K. (2021) · Diabetes · doi:10.2337/db20-0297 · Cited by 15
Development of electrochemical Zn2+ sensors for rapid voltammetric detection of glucose-stimulated insulin release from pancreatic β-cells
Vanderlaan, E. L., Nolan, J. K., Sexton, J., Evans‐Molina, C., Lee, H., & Voytik‐Harbin, S. L. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115409 · Cited by 18
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
Lansberry, T. R., & Stabler, C. L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115179 · Cited by 20
Cerium and Yttrium Oxide Nanoparticles and Nano-selenium Produce Protective Effects Against H2O2-induced Oxidative Stress in Pancreatic Beta Cells by Modulating Mitochondrial Dysfunction
Tavoosi, S., Baghsheikhi, A. H., Shetab-Boushehri, S. V., Nigjeh, M. N., Sarvestani, N. N., Karimi, M. Y., Ranjbar, A., Ebadollahi‐Natanzi, A., & Hosseini, A. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666191002154659 · Cited by 17
Pancreas transplantation today: quo vadis?
Al-Naseem, A., Attia, A., Gonnah, A. R., Al-Naseem, A. O. A. S., Spiers, H. V. M., Gruessner, A. C., Leelarathna, L., Thabit, H., & Augustine, T. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad032 · Cited by 19
Subcutaneous device-free islet transplantation
Zhou, X., Xu, Z., You, Y., Yang, W., Bingzheng, F., Yang, Y., Li, F., Chen, J., & Gao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287182 · Cited by 16
VEGF-Modified PVA/Silicone Nanofibers Enhance Islet Function Transplanted in Subcutaneous Site Followed by Device-Less Procedure
Yang, B., Cao, G., Cai, K., Wang, G., Li, P., Zheng, L., Cai, H., Zhu, Y., Li, X., & Wu, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s232224 · Cited by 16
In Vivo Imaging of Pancreatic Islet Grafts in Diabetes Treatment
Arifin, D., & Bulte, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640117 · Cited by 12
Role of the Pancreatic Islet Microvasculature in Health and Disease
Aplin, A. C., Aghazadeh, Y., Mohn, O. G., & Hull, R. L. (2024) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554241299862 · Cited by 21
Hypoxia-Preconditioned Wharton’s Jelly-Derived Mesenchymal Stem Cells Mitigate Stress-Induced Apoptosis and Ameliorate Human Islet Survival and Function in Direct Contact Coculture System
Keshtkar, S., Kaviani, M., Jabbarpour, Z., Sarvestani, F. S., Ghahremani, M. H., Esfandiari, E., Aghdaei, M. H., Nikeghbalian, S., Shamsaeefar, A., Geramizadeh, B., et al. (2020) · Stem Cells International · doi:10.1155/2020/8857457 · Cited by 15
Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells
Kahraman, S., Manna, D., Dirice, E., Maji, B., Small, J. C., Wagner, B. K., Choudhary, A., & Kulkarni, R. (2021) · Life Science Alliance · doi:10.26508/lsa.202000840 · Cited by 17
Comparative Study of Two Common In Vitro Models for the Pancreatic Islet with MIN6
Chao, X., Zhao, F.-R., Hu, J.-W., Yu, Y.-R., Xie, R.-J., Zhong, J.-N., Huang, M., Zeng, T., Yang, H., Luo, D., et al. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00507-8 · Cited by 12
Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes
Lin, J.-R., Huang, S., Wu, C., Chen, Y.-W., Hong, Z., Cheng, C.-P., Sytwu, H., & Lin, G. (2021) · Pharmaceuticals · doi:10.3390/ph14050475 · Cited by 14
Formulation strategies to provide oxygen-release to contrast local hypoxia for transplanted islets
Wang, Z., Jiang, Z., Lu, R., Kou, L., Zhao, Y., & Yao, Q. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.015 · Cited by 16
Recent progress in pancreatic islet cell therapy
Sim, E. Z., Shiraki, N., & Kume, S. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-020-00152-5 · Cited by 15
Promises and pitfalls of beta cell–replacement therapies
Kolic, J., & Johnson, J. D. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00433-4 · Cited by 13
Long-Term Survival and Induction of Operational Tolerance to Murine Islet Allografts by Co-Transplanting Cyclosporine A Microparticles and CTLA4-Ig
Kuppan, P., Wong, J., Kelly, S., Lin, J.-X., Worton, J., Castro, C., Paramor, J., Seeberger, K., Cuesta-Gomez, N., Anderson, C., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092201 · Cited by 11
Self-citation
Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells
Grebinoski, S., Pieklo, G. P., Zhang, Q., Visperas, A., Cui, J., Goulet, J., Xiao, H., Brunazzi, E. A., Cardello, C., Herrada, A. A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300216 · Cited by 13
Using GRGDSPC peptides to improve re‐endothelialization of decellularized pancreatic scaffolds
Wan, J., Wang, L., Huang, Y. H., Fan, H., Chen, C., Yuan, X., Guo, Y., & Yin, L. (2019) · Artificial Organs · doi:10.1111/aor.13602 · Cited by 12
Bioengineered Islet Cell Transplantation
Bellofatto, K., Moeckli, B., Wassmer, C., Laurent, M., Oldani, G., Andrès, A., Berney, T., Berishvili, E., Toso, C., & Peloso, A. (2021) · Current Transplantation Reports · doi:10.1007/s40472-021-00318-1 · Cited by 15
Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles
Neshat, S. Y., Bauer, S. J., Rhodes, K. R., Quiroz, V. M., Wong, V. W. K., Lowmaster, S. M., Tzeng, S. Y., Green, J. J., & Doloff, J. C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00329 · Cited by 11
Exosome-Mediated Differentiation of Mouse Embryonic Fibroblasts and Exocrine Cells into β-Like Cells and the Identification of Key miRNAs for Differentiation
Mandal, P., De, D., Im, D. U., Um, S. H., & Kim, K. K. (2020) · Biomedicines · doi:10.3390/biomedicines8110485 · Cited by 10
A simple method of hiPSCs differentiation into insulin-producing cells is improved with vitamin C and RepSox
Horikawa, A., Mizuno, K., Kyoko, T., Yamamoto, T., & Michiue, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254373 · Cited by 9
Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
Karras, S. Ν., Koufakis, T., Zebekakis, P. E., & Kotsa, K. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i4.234 · Cited by 9
Improvement of human pancreatic islet quality after co-culture with human adipose-derived stem cells.
de Souza, B. D., Rodrigues, M., de Oliveira, F. S., da Silva, L. A., Bouças, A. P., Portinho, C. P., Santos, B. P. D., Camassola, M., Rocha, D., Lysakowski, S., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110729 · Cited by 3
Heterogeneity and neurovascular integration of intraportally transplanted islets revealed by 3-D mouse liver histology
Chen, C., Peng, S.-J., Wu, P.-Y., Chien, H., Lee, C., Chung, M., & Tang, S. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00605.2020 · Cited by 9
Nrf2: Therapeutic target of islet function protection in diabetes and islet transplantation
Wei, B., Zhang, X., Qian, J., Tang, Z., & Zhang, B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115463 · Cited by 8
How stem cells could fix type 1 diabetes
Drew, L. (2021) · Nature · doi:10.1038/d41586-021-01842-x · Cited by 9
Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy
Capuani, S., Campa‐Carranza, J. N., Hernandez, N., Chua, C. Y. X., & Grattoni, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304003 · Cited by 10
Experimental study of ultrasound retention of bubble-surrounded cells under various conditions of acoustic field and flow velocity
Chikaarashi, T., Watanabe, S., Miyamoto, Y., Omata, D., Maruyama, K., Suzuki, R., & Masuda, K. (2022) · Japanese Journal of Applied Physics · doi:10.35848/1347-4065/ac54f9 · Cited by 8
Formation of Re-Aggregated Neonatal Porcine Islet Clusters Improves In Vitro Function and Transplantation Outcome
Honarpisheh, M. M., Lei, Y., Zhang, Y., Pehl, M., Kemter, E., Kraetzl, M., Lange, A., Wolf, E., Buerck, L. W., & Seißler, J. (2022) · Transplant International · doi:10.3389/ti.2022.10697 · Cited by 8
Identifying and optimizing critical process parameters for large-scale manufacturing of iPSC derived insulin-producing β-cells
Yehya, H., Wells, A., Majcher, M., Nakhwa, D., King, R., Senturk, F., Padmanabhan, R., Jensen, J., & Bukys, M. A. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03973-0 · Cited by 7
Combined islet and kidney xenotransplantation for diabetic nephropathy: an update in ongoing research for a clinically relevant application of porcine islet transplantation
Eisenson, D. L., Iwase, H., Chen, W., Hisadome, Y., Cui, W., Santillan, M. R., Schulick, A. C., Gu, D., Maxwell, A., Koenig, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1351717 · Cited by 7
Development of Advanced Cell-Based Therapy by Regulating Cell–Cell Interactions
Kusamori, K. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00276 · Cited by 7
The best protection is early detection
Kattner, A. A. (2021) · Biomedical Journal · doi:10.1016/j.bj.2022.01.010 · Cited by 7
Which stem cells will eventually translate to the clinics for treatment of diabetes?
Bhartiya, D., & Mohammad, S. A. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01718-3 · Cited by 7
Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes
Nagaya, M., Hasegawa, K., Uchikura, A., Nakano, K., Watanabe, M., Umeyama, K., Matsunari, H., Osafune, K., Kobayashi, E., Nakauchi, H., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.306 · Cited by 7
Novel Functional Genes Involved in Transdifferentiation of Canine ADMSCs Into Insulin-Producing Cells, as Determined by Absolute Quantitative Transcriptome Sequencing Analysis
Dai, P., Li, J., Chen, Y., Zhang, L., Zhang, X., Wang, J., Qi, G., & Zhang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685494 · Cited by 7
Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy
So, W. Y., Liao, Y., Liu, W. N., Rutter, G. A., & Han, W. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317928 · Cited by 6
Noninvasive Tracking of mPEG-poly(Ala) Hydrogel-Embedded MIN6 Cells after Subcutaneous Transplantation in Mice
Juang, J., Lin, H.-C., Chen, C.-Y., Kao, C.-W., Chen, C.-L., Wu, S.-T., Lin, S., Shen, C., Wang, J., Tsai, Z., et al. (2021) · Polymers · doi:10.3390/polym13060885 · Cited by 7
Advances and challenges of endocrine pancreas bioengineering
Hanna, R., & Berishvili, E. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100320 · Cited by 6
T helper-9 cells and Interleukin-9 in transplantation: The open question
Assadiasl, S., Fatahi, Y., & Nicknam, M. H. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.03.006 · Cited by 6
Microvesicles facilitate the differentiation of mesenchymal stem cells into pancreatic beta-like cells via miR-181a-5p/150-5p
Ning, M., Hua, S., Ma, Y., Liu, Y., Wang, D., Xu, K., & Yu, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127719 · Cited by 6
Chemical Strategies for Improving Islet Transplant Outcomes
Quintana, J. M., Stinchcomb, A. L., Kostyo, J. H., Robichaud, B., Plunk, M. A., & Kane, R. R. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1804036 · Cited by 6
Type 1 Diabetes in Youth and Technology-Based Advances in Management
Ferber, C., Mao, C. S., & Yee, J. K. (2020) · Advances in Pediatrics · doi:10.1016/j.yapd.2020.04.002 · Cited by 8
Will pigs solve the organ crisis? The future of animal-to-human transplants
Reardon, S. (2022) · Nature · doi:10.1038/d41586-022-03794-2 · Cited by 6
Progress in islet xenotransplantation: Immunologic barriers, advances in gene editing, and tolerance induction strategies for xenogeneic islets in pig-to-primate transplantation
Eisenson, D. L., Hisadome, Y., Santillan, M. R., & Yamada, K. (2022) · Frontiers in Transplantation · doi:10.3389/frtra.2022.989811 · Cited by 5
Augmenting engraftment of beta cell replacement therapies for T1DM
Aggarwal, S., Pepper, A. R., & Jahdhami, N. A. (2021) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2021.100058 · Cited by 5
Self-citation
From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment
Carvalho, A. M., Nunes, R., & Sarmento, B. F. C. C. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106148 · Cited by 5
Pancreatic islet cell transplantation
Ün, M. (2020) · Demiroglu Science University Florence Nightingale Transplantation Journal · doi:10.5606/dsufnjt.2019.003 · Cited by 5

Authors: Gamble, A., Pepper, A. R., Bruni, A., & Shapiro, A. M. J.
Affiliations: University of Alberta (CA)
Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada
Corresponding author: Shapiro, A. M. James
ORCID: Gamble, Anissa
Pepper, Andrew R.
Bruni, Antonio
Shapiro, A. M. James
Venue: Islets
Publisher: Informa UK Limited
Published: 2018-02-05
Volume: 10
Issue: 2
Pages: 80-94
ISSN: 1938-2014 (ISSN-L)
1938-2022
DOI: 10.1080/19382014.2018.1428511
PMC: PMC5895174
OpenAlex: W2791423015
Cited by: 171
References: 133
Citations by year: 2026: 7 · 2025: 16 · 2024: 14 · 2023: 29 · 2022: 30 · 2021: 32 · 2020: 32 · 2019: 9 · 2018: 2
FWCI: 4.17
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Islets (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Diabetes Research Institute Foundation
Stem Cell Network
Alberta Innovates
National Institutes of Health
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: islet transplantation, type 1 diabetes, graft loss, islet engraftment, hypoglycemia prevention, insulin independence, islet autoimmunity, immunosuppressants, beta-cell toxicity, intraportal transplantation, mesenchymal stem cells, immunoprotection
MeSH terms: Animals, Diabetes Mellitus, Type 1, Graft Survival, Humans, Islets of Langerhans, Autoimmunity, Islets of Langerhans Transplantation, Neovascularization, Physiologic, Tissue and Organ Harvesting, Pluripotent Stem Cells, Mesenchymal Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The journey of islet cell transplantation and future development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks